Colgate-Palmolive (NYSE:CL) Shares Sold by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 3.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,537 shares of the company’s stock after selling 668 shares during the period. Bahl & Gaynor Inc.’s holdings in Colgate-Palmolive were worth $1,776,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. D Orazio & Associates Inc. boosted its holdings in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares during the period. Commonwealth Financial Services LLC boosted its holdings in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after acquiring an additional 118 shares during the period. Lantz Financial LLC boosted its holdings in shares of Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after acquiring an additional 122 shares during the period. Horizon Kinetics Asset Management LLC boosted its holdings in shares of Colgate-Palmolive by 4.2% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock valued at $322,000 after acquiring an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc boosted its holdings in shares of Colgate-Palmolive by 1.0% during the fourth quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company’s stock valued at $1,182,000 after acquiring an additional 130 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 1.9 %

Shares of NYSE CL opened at $91.09 on Wednesday. The stock has a market cap of $73.92 billion, a price-to-earnings ratio of 25.88, a PEG ratio of 4.20 and a beta of 0.44. The business has a 50 day simple moving average of $88.73 and a 200 day simple moving average of $95.29. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm earned $0.87 EPS. On average, research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.20%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CL. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday. Finally, Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.